Abiogen Pharma
Manufacturing · Italy · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Via Antonio Meucci 36, Pisa, Tuscany, 56...Phone Number
+39 503154101Website
www.abiogen.itRevenue
$16.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Abiogen Pharma
Abiogen Pharma is a pharmaceutical company with over a century of history, specializing in therapeutic areas such as bone metabolism, vitamin D deficiency, pain management, dermatology, respiratory issues, and diabetology. The company is recognized for its commitment to scientific research, technological innovation, and internationalization, serving as a reference point for the medical community. Abiogen Pharma offers a range of products including pharmaceuticals, dietary supplements, medical devices, and special medical foods. With a strong presence in over 40 countries and a projected revenue of 168 million in 2024, Abiogen Pharma continues to evolve while maintaining its core values across five generations.Explore more
Abiogen Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Abiogen Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Abiogen Pharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Abiogen Pharma launches new products
Funding: Get notified immidiatlly once Abiogen Pharma has new funding data
Abiogen Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Abiogen Pharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Abiogen Pharma
Check if Abiogen Pharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Abiogen Pharma recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Abiogen Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Abiogen Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Abiogen Pharma.
Abiogen Pharma Tech Stack
A closer look at the technologies used by Abiogen Pharma
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Hiring Plans
Abiogen Pharma has more open roles in Sales than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Abiogen Pharma is hiring in Information Technology for the first time in 12 months.
Hiring Plans
Project
A front-line source has indicated that the IT department's biggest priority over the three months will focus on computer security efforts.
Information Security, Desktop, Security
Project
Spending/Investment, Information Security, Infrastructure, Contingent Workforce, Financial Planning, Help Desk, Enterprise Software, Security, Software
Abiogen Pharma News & Media
Abiogen Pharma Acquires 97,09% Stake in EffRx Pharmaceuticals
Abiogen Pharma, a Pisa, Italy-based company focused on osteoarticular and bone metabolism diseases, acquired a 97,09% stake in EffRx Pharmaceuticals, a Freienbach, Switzerland-based company that develops and markets prescription drugs targeted in particular to musculoskeletal and rare pathologies on European and international markets. The amount of the deal was not disclosed. With the acquisition, Abiogen […] The post Abiogen Pharma Acquires 97,09% Stake in EffRx Pharmaceuticals appeared first oABIOGEN PHARMA COMPLETES THE ACQUISITION OF EFFRX
PISA, Italy, May 29, 2023 /PRNewswire/ -- Abiogen Pharma S.p.A., Italian leading company in the field of osteoarticular and bone metabolism diseases, is pleased to announce the acquisition of a 97,09% stake in EffRx Pharmaceuticals SA, a Swiss company that develops and markets...Abiogen Pharma Completes Acquisition of Altamedics
Abiogen Pharma, a Pisa, Italy-based pharmaceutical manufacturing company, acquired Altamedics GmbH, a Cologne, Germany-based company that focuses on the distribution of pharmaceuticals in hospital settings, as well as of specialty and high-value-added products. The amount of the deal was not disclosed. With the acquisition, Abiogen Pharma will expand its offerings. Altamedics GmbH distributes pharmaceuticals, namely […] The post Abiogen Pharma Completes Acquisition of Altamedics appeared first oABIOGEN PHARMA ACQUIRED ALTAMEDICS
Altamedics is a pharmaceutical distributor based in Germany and operating on European and non-European markets Through the acquisition of the German company, Abiogen Pharma has completed the first step of its internationalisation process started in 2015 Thanks to this agreement, Abiogen...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Abiogen Pharma
Sign Up For FreeTo access detailed company insights
Abiogen Pharma is a pharmaceutical company with over a century of history, specializing in therapeutic areas such as bone metabolism, vitamin D deficiency, pain management, dermatology, respiratory issues, and diabetology. The company is recognized for its commitment to scientific research, technological innovation, and internationalization, servin... Read More
